Medspa Expansion: Navigating the Regulatory Minefield for Compliant Growth

By Shannon Smith, DNP, APRN, FNP-C, PMHNP-BC, PMHNP-C · 2026-04-17

Expanding a medspa operation promises significant revenue growth, but the regulatory landscape is fraught with complexities. This guide offers a compliance-first roadmap for scaling your medspa, ensuring sustainable growth while mitigating critical legal and operational risks.

The aesthetics industry is booming, with the global medical spa market projected to reach over $33 billion by 2030. For ambitious medspa owners, this presents an enticing opportunity for expansion. However, the path to scaling a medspa is not merely about identifying new locations or services; it's a complex journey through a dense thicket of healthcare regulations. Without a compliance-first strategy, rapid expansion can quickly turn into a liability nightmare, jeopardizing your practice, your license, and your financial future.

At TrueEval, we understand that growth without compliance is not growth at all. This article will dissect the critical regulatory checkpoints for medspa expansion, offering actionable insights to build a robust, multi-location, or multi-service operation that stands up to scrutiny.

> For more on this topic, see our analysis: [Telehealth's Tightening Grip: DEA, DOJ, and State Boards Signal a New Era of Scrutiny](/blog/telehealth-tightening-grip-dea-doj-state-boards-scrutiny).

The Bedrock of Expansion: Corporate Practice of Medicine (CPOM) and Scope of Practice

Before even considering a second location or new service, every medspa owner must deeply understand the Corporate Practice of Medicine (CPOM) doctrine and scope of practice laws in their target states. These are not abstract legal concepts; they are the fundamental rules dictating who can own a medical practice, who can employ licensed professionals, and what services those professionals can legally perform.

> For more on this topic, see our analysis: [Telehealth Tensions: Navigating DEA Scrutiny, CPOM Landmines, and State Board Enforcement in a Post-PHE World](/blog/telehealth-tensions-dea-cpom-state-board-enforcement).

Corporate Practice of Medicine (CPOM): Your Ownership Structure Matters

CPOM laws prevent corporations or non-licensed individuals from employing physicians or controlling medical decision-making. While some states have relaxed CPOM rules, many, like Iowa and Kentucky, maintain strict enforcement. As highlighted in recent analyses, Iowa's CPOM doctrine is particularly stringent, prohibiting non-licensed entities from employing physicians or controlling medical services. Kentucky, while moderate, still requires careful adherence to professional ownership structures.

Implications for Medspas:

  • Ownership: If your medspa offers medical services (e.g., injectables, laser treatments, advanced peels), the entity providing those services must typically be owned by licensed medical professionals (e.g., physicians, PAs, NPs) within a compliant professional corporation (PC) or professional limited liability company (PLLC).
  • Management Service Organizations (MSOs): The MSO model is a common strategy for non-physician entrepreneurs to participate in the medspa business. An MSO provides administrative, marketing, and technological support to an independently owned professional entity. However, the MSO cannot dictate clinical decisions, employ licensed medical staff who perform medical services, or engage in fee-splitting. The financial arrangements between the MSO and the professional entity must be at fair market value for the administrative services provided, independent of the volume or value of medical services.
  • Active Medical Direction: A medical director is not a figurehead. State boards, such as the Michigan Board of Medicine, are actively monitoring and enforcing regulations related to medspa operations, with disciplinary actions often stemming from inadequate supervision. Your medical director must be actively engaged, providing direct, on-site supervision as required by state law, and operating within their scope of practice. This includes reviewing charts, establishing protocols, and ensuring staff competency.

Actionable Insight: Before expanding into a new state, conduct a thorough CPOM analysis. Engage legal counsel specializing in healthcare regulatory law to structure your entity compliantly. This might mean forming a new professional entity in each state or meticulously drafting MSO agreements that withstand scrutiny.

Scope of Practice: Who Can Do What?

Each state defines what services licensed professionals (physicians, PAs, NPs, RNs, LPNs, estheticians) can perform. These definitions vary significantly and are often the source of enforcement actions.

Implications for Medspas:

  • Delegation: Services like injectables (e.g., Botox, fillers) and certain laser treatments often require delegation from a physician. The rules for delegation (e.g., direct supervision, indirect supervision, on-site presence) are state-specific. For example, a registered nurse performing an injectable procedure might require a physician to be physically present in one state, while another state allows for off-site supervision.
  • Estheticians: Understand the strict limitations on esthetician scope. They generally cannot perform medical procedures, diagnose conditions, or use devices that penetrate the dermis. Misrepresentation of services or provider qualifications is a significant risk area that the Michigan Board of Medicine, among others, is scrutinizing.
  • New Services: Adding new services (e.g., IV hydration, hormone therapy, advanced body contouring) requires a fresh scope of practice review. Can your current staff perform these? Do you need to hire new professionals? What level of supervision is required?

Actionable Insight: Create a detailed matrix of services offered and the licensure requirements for each professional performing them in every state where you operate or plan to operate. This matrix should also include the required level of physician supervision. Train your staff rigorously on these distinctions.

The Telehealth Frontier: Expanding Reach with Caution

Many medspas are exploring telehealth to offer initial consultations, follow-up care, or even prescribe certain medications (e.g., for weight loss, hormone therapy). While telehealth offers immense potential for reach, it introduces a new layer of regulatory complexity.

Establishing a Valid Provider-Patient Relationship

States have varying requirements for establishing a valid provider-patient relationship via telehealth, which is a prerequisite for prescribing. The District of Columbia, for instance, explicitly requires an initial real-time, interactive audio-visual examination for prescribing, with limited exceptions. Asynchronous modalities or audio-only calls are generally insufficient for initiating a prescribing relationship, particularly for new patients.

Implications for Medspas:

  • Consultations: If you're offering virtual consultations, ensure your platform supports real-time audio-visual interactions and that your protocols align with state-specific requirements for establishing a patient relationship.
  • Prescribing: If your medspa prescribes medications (e.g., GLP-1 agonists for weight loss), the rules become even more stringent. The DEA's proposed rules for controlled substances, though still evolving, emphasize the need for an in-person medical evaluation for initial prescriptions of Schedule II and certain Schedule III-V controlled substances. Even for non-controlled substances, the standard of care for telehealth must be equivalent to in-person care.

Actionable Insight: Implement robust patient intake and telehealth interaction protocols. Document every step, including informed consent for telehealth services. If prescribing, ensure your providers are licensed in the patient's state and adhere to both federal (e.g., DEA) and state prescribing guidelines. Prepare for a hybrid model that may require in-person visits for certain prescriptions.

DOJ Scrutiny and Controlled Substances

The Department of Justice (DOJ) has significantly intensified enforcement against telehealth companies and practitioners involved in illegal prescribing and distribution of controlled substances. This trend underscores the critical importance of a "legitimate medical purpose" for all prescriptions, especially for controlled substances. The DOJ is scrutinizing whether telehealth platforms facilitate practices that circumvent this standard.

Implications for Medspas:

  • Risk Mitigation: While medspas may not be primary prescribers of controlled substances, any involvement in weight loss or hormone therapy that *could* involve controlled substances (e.g., certain stimulants or testosterone) puts you under this enhanced scrutiny.
  • Compliance Programs: Robust compliance programs, regular audits of prescribing patterns, and clear policies prioritizing patient safety and regulatory adherence are essential. This includes meticulous record-keeping, patient identification, and processes for handling red flags related to potential drug-seeking behavior.

Actionable Insight: If your medspa considers any service involving controlled substances, consult with legal counsel immediately. Ensure your providers have appropriate DEA registrations in each state where they prescribe. The complexity of DEA registration for cross-state telehealth is a significant hurdle that requires expert navigation.

Financial Structures and Anti-Kickback Laws

As you expand, your financial arrangements, particularly with referral sources or marketing partners, come under increased scrutiny. Federal and state Anti-Kickback Statutes (AKS) and Stark Law (for physician referrals of designated health services) prohibit offering or receiving remuneration for referrals.

Implications for Medspas:

  • Referral Networks: Building referral networks with dermatologists, plastic surgeons, or primary care providers is common. However, any financial arrangement must be structured to avoid AKS violations. This means no payments for referrals, only for legitimate services rendered at fair market value.
  • Marketing Agreements: Be cautious with joint marketing ventures or lead generation services. Ensure compensation is not tied to the volume or value of referrals or services provided.
  • Fee-Splitting: Many states prohibit fee-splitting, where a licensed professional shares a percentage of their professional fees with an unlicensed entity or individual. This ties back directly to CPOM concerns and is a common pitfall for MSO arrangements that are not meticulously structured.

Actionable Insight: All financial agreements, particularly those involving referrals or marketing, should be reviewed by healthcare compliance counsel. Ensure they fall within safe harbors or exceptions to AKS and Stark Law, and comply with state-specific prohibitions on fee-splitting.

Staffing, Credentialing, and Training

Scaling your medspa means scaling your team. This is not just about hiring; it's about ensuring every team member is qualified, properly credentialed, and continuously trained on compliance.

Implications for Medspas:

  • Licensure Verification: For every new hire, meticulously verify their professional license in the state(s) where they will practice. This includes checking for disciplinary actions.
  • Competency and Training: Ensure all staff, especially those performing delegated medical procedures, are adequately trained and demonstrate competency. Document all training. The Michigan Board of Medicine, for example, expects clear delineation of services and that all procedures are performed by licensed professionals within their scope.
  • Ongoing Education: Regulatory landscapes evolve. Regular, mandatory compliance training for all staff on CPOM, scope of practice, patient privacy (HIPAA), and emergency protocols is non-negotiable.

Actionable Insight: Implement a robust credentialing and privileging process for all clinical staff. Develop a comprehensive compliance training program that is updated annually and whenever new regulations or services are introduced. Consider a dedicated compliance officer or external compliance consultant as you grow.

Technology and Data Security

Expansion often means leveraging new technologies for patient management, marketing, and telehealth. Each technology introduces data security and privacy considerations.

Implications for Medspas:

  • HIPAA Compliance: All patient data must be protected under HIPAA. This means secure electronic health records (EHRs), encrypted communications, and Business Associate Agreements (BAAs) with all third-party vendors who handle Protected Health Information (PHI).
  • Telehealth Platforms: Ensure your telehealth platform is HIPAA-compliant, offers secure video conferencing, and allows for proper documentation of encounters.
  • Marketing Data: Be mindful of how you collect and use patient data for marketing. Ensure consent is obtained for marketing communications.

Actionable Insight: Conduct regular security risk assessments. Vet all technology vendors for HIPAA compliance. Train staff on data privacy best practices and incident response protocols.

What This Means For Your Practice

Expanding your medspa is an exciting venture, but it demands a strategic, compliance-first approach. The regulatory environment is dynamic and increasingly stringent, with federal agencies like the DOJ and state boards actively monitoring and enforcing regulations. The cost of non-compliance—fines, license revocation, criminal charges, and reputational damage—far outweighs the investment in proactive legal and compliance infrastructure.

Key Takeaways for Compliant Medspa Expansion:

1. Deep Dive into State Laws: Before entering any new state or launching a new service, conduct exhaustive research on CPOM, scope of practice, and telehealth regulations. This often requires state-specific legal counsel. 2. Structure for Success: Design your legal and operational structures (e.g., MSOs, professional corporations) to explicitly separate clinical and administrative functions, ensuring physician independence and avoiding fee-splitting. 3. Rigorous Credentialing and Training: Invest in robust processes for verifying licenses, ensuring competency, and providing ongoing compliance training for all staff. 4. Proactive Risk Management: Implement a comprehensive compliance program, conduct regular internal audits, and stay abreast of evolving regulations, particularly concerning telehealth and controlled substance prescribing. 5. Engage Expert Counsel: Do not attempt to navigate these complexities alone. Partner with experienced healthcare attorneys and compliance professionals who understand the nuances of medspa regulations.

By embedding compliance into the very fabric of your expansion strategy, you not only mitigate risk but also build a more resilient, reputable, and ultimately, more successful medspa enterprise. TrueEval is dedicated to providing the infrastructure and insights you need to achieve this compliant growth, transforming regulatory challenges into strategic advantages.


Further Reading

  • [Telehealth Tensions: Navigating DEA Scrutiny, CPOM Landmines, and State Board Enforcement in a Post-PHE World](/blog/telehealth-tensions-dea-cpom-state-board-enforcement)
  • [Telehealth's Tightening Grip: DEA, DOJ, and State Boards Signal a New Era of Scrutiny](/blog/telehealth-tightening-grip-dea-doj-state-boards-scrutiny)
  • [Michigan's Regulatory Gauntlet: Navigating Telehealth, Medspas, and CPOM in the Wolverine State](/blog/michigan-telehealth-medspa-cpom-compliance)